Pfizer Says Zoloft Defect Claims Still Suffer Lack Of Science
By Sindhu Sundar ( March 23, 2016, 9:52 PM EDT) -- Pfizer Inc. has continued to fight parents targeting the drugmaker in multidistrict litigation over the alleged birth defect risks of its antidepressant Zoloft, arguing in Pennsylvania federal court that a recent submission by the parents purporting to be a recent epidemiology study is actually just a statement by the American Statistical Association....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.